Pioneering Study Reveals No Increased Pneumonia Risk in COPD Patients Using Extrafine Beclometasone Dipropionate in Inhaler Therapy
A ground-breaking study conducted by an international consortium of leading respiratory experts sheds new light on the management of COPD